Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)
Incyte Corporation
Incyte Corporation
Incyte Corporation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Incyte Corporation
City of Hope Medical Center